Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Am J Orthod Dentofacial Orthop ; 131(3): 321-6, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17346586

ABSTRACT

The pharmacologic agent bisphosphonate has recently received much attention in the dental literature. Bisphosphonates in oral or intravenous forms are used to treat various diseases such as certain cancers, bone- and calcium-related disorders, osteoporosis, and osteopenia. Bisphosphonates inhibit bone turnover and result in increased bone-mineral density. The most serious dental side effect of bisphosphonate treatment (particularly when it is administered intravenously) is, paradoxically, osteonecrosis of the mandible or the maxilla represented by exposed nonhealing bone. Other related complications include decreased bone healing and inhibition of orthodontic tooth movement. This article reports the orthodontic treatment of 2 patients who were taking bisphosphonates.


Subject(s)
Bone Density Conservation Agents/adverse effects , Diphosphonates/adverse effects , Mandibular Diseases/chemically induced , Orthodontic Space Closure/adverse effects , Osteonecrosis/chemically induced , Addison Disease/drug therapy , Adult , Aged , Female , Humans , Male , Malocclusion, Angle Class II/diagnostic imaging , Malocclusion, Angle Class II/therapy , Mandibular Diseases/diagnostic imaging , Multiple Myeloma/drug therapy , Osteonecrosis/diagnostic imaging , Radiography , Tooth Extraction/adverse effects , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...